Navigation Links
GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
Date:9/25/2007

ST. JOSEPH, Mich., Sept. 25 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that Bristol-Myers Squibb (NYSE: BMY) has licensed access to all major GeneGo products. Using the licensed GeneGo technology, research and development sites within Bristol-Myers Squibb will have the ability to start with chemical compound structures and/or genomics data to address questions from both chemistry and biology domains. Bristol-Myers Squibb can also access GeneGo tools to build their own canonical pathway maps using public, GeneGo, and proprietary data and have those maps included in statistical calculations and overlays. In addition, Bristol Myers Squibb researchers can leverage GeneGo products to overlay their own internal interaction data in the context of manually curated pathways for more elucidation.

"Bristol Myers Squibb is very important to GeneGo as they have excellent scientists who we have been collaborating with," said Julie Bryant, GeneGo's VP of Business Development. "We plan to continue this collaborative spirit over the next few years."

About GeneGo

GeneGo develops systems biology technology for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.0(TM), assists pharmaceutical scientists in the areas of target selection and validation, identification of biomarkers for disease states and toxicology
'/>"/>

SOURCE GeneGo, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. WARF enters licensing agreements for stem cell products
2. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
3. Software company enters health space with RFID solutions on hold
4. Lucigen Corp. enters global licensing agreement
5. Call centers and customer service: The good, the bad, and the clueless
6. GE Healthcare enters agreement with Canadian health authority
7. Data centers: Buyers beware of over-hyped facilities
8. Data centers: Blowing smoke and raising red flags
9. Prodesse enters patent agreement with Roche
10. UW-Madison enters Kauffman grant competition
11. Applied Technology Centers to aid printing and manufacturing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...swire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ...rmaceutical company focused on endocrine therapy a...d Drug Administration (FDA) has granted Fast Track...hibitor compound, perifosine (KRX-0401), for the t...Keryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), ...
(Date:12/1/2009)...lomon announced that he has joined Carolina Eyecar...te at www.DrKerrySolomon.com , which was develope...roven LASIK, lens implant, and cataract surgery ex...s substantial contributions to improving vision co... Surgeons, which screens LASIK surgeons based upon...
(Date:12/1/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, Emerging Clinical Trial Locations - Ea...lthcare and regulatory environment ,, http://...ial-Locations---Eastern-Europe-Market-dynamics-and...t.html ,, Over the last decade pharmaceutical ...
(Date:12/1/2009)...ewswire-Asia/ -- Shanghai ChemPartner, as the,flag...sed Contract Research,Organization (CRO), today an...logy Fast 50 China, ranking 3rd on the list of the... award is a testament to ChemPartner,s outstanding..., The results of the 2009 Deloitte Technology...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3
...JUPITER, Fla., Jan. 13 Level 3 Inspection LLC (L3...nt System (QMS) development by,meeting or exceedin...,Certification under the rules of the aerospace st...mpliance and zero non-compliance issues. , Sta..., Scott McAfee led,the creation, organization and ...
...TAI,AN CITY, China, Jan. 13 /PRNewswire-Asia-First...in Board: CBPO) ("China Biologic" or the "Company"...ompanies in the People,s,Republic of China ("PRC")...,Products Co., Ltd. ("Taibang"), a Chinese subsidi... loan ("the Loan Agreement") with the Bank of Chin...
...BOSTON, Jan. 13 Responding to the increased risk ...ional Patient Safety Foundation,has announced that...ly address,this issue through an extensive program...dees with the new thinking and tools critical to k...wscom.com/cgi-bin/prnh/20080307/AQF053LOGO ) , ...
Other Biology Technology:Level 3 Inspection Achieves 100% Compliance in ISO 9001 & AS 9100 Certification 2China Biologic Products Enters into Short-Term Loan Agreement 2China Biologic Products Enters into Short-Term Loan Agreement 3Patient Safety in Challenging Economic Times is Focus of NPSF Annual Congress on May 20-22 2
(Date:12/1/2009)... . , Brown adipose tissue is different from wh...miniature power stations which among other things ...ate a voltage similar to that of a battery, which ...er, the mitochondria of brown fat cells have a sho... The energy released when the fat is broken down i...
(Date:12/1/2009)...Inserm Grand Prix., Every year since 2000, Inser... outstanding,work performed in its laboratories a...ds to,demonstrate the diversity and wealth of act...d,health research, and the creativity and passion...s research each day. The Inserm 2009 prize-giving ...
(Date:12/1/2009)...ire/ -- iQor, a global provider of business proces...2009 InfoWorld 100 Awards Top 100 IT project of ...This was the first submission for iQor. ,, "We ...s list of companies," said Vikas Kapoor, president...g the way we do business, allowing us to work fast...
Breaking Biology News(10 mins):Brown fat cells make 'spare tires' shrink 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 1Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 2Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 3Cytokine PharmaSciences Initiates Phase I Study of Oral Anti Inflammatory Agent CPSI 2364 4746 1Cytokine PharmaSciences Initiates Phase I Study of Oral Anti Inflammatory Agent CPSI 2364 4746 2l a Hospitals Struggle for Emergency Room Care Pay Physicians High Fees for On Call Coverage 52092 1l a Hospitals Struggle for Emergency Room Care Pay Physicians High Fees for On Call Coverage 52092 2
...o manipulate computer cursors for fruit juice rewa...ter plans behaviors not by specifying movements re...at will result from those actions. , The distincti...t yields new basic insight into a central function...n, called the lateral prefrontal cortex (PFC). ,...
...en under age 6 in Massachusetts over 22 years, a n...pecially infants--are now more likely to be overwe...bulatory Care and Prevention of Harvard Medical Sc...n the July issue of Obesity. , "The obesity epidem...dren," says Matthew Gillman, MD, senior author of ...
... for alcohol has yielded a rapid, inexpensive way ...ke beat cops keeping misguided cells from attackin...mbers of these cells opens the door to improved tr...iseases such as type 1 diabetes and arthritis, Med...ls are components of the immune system designed to...
Other Biology News:Himalayan forests disappearing 2Today's babies are fatter babies 2Finding paves way for better treatment of autoimmune disease 2
Maxi XL Hybridization Oven from Thermo Scientific
Shake 'n' Stack oven - New Model from Thermo Scientific
DNase I from Invitrogen
...clone of the human Topoisomerase II gene. Desc...tate of nucleic acids by passing an intact DNA hel...arate DNA helix (1,2) . As a result of its double-...ax negatively or positively supercoiled DNA, as we...
Biology Products: